TriSalus Life Sciences, Inc. ( TLSI) - Key Metrics
TLSI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.20 | -$0.16 | -$0.28 | -$0.29 |
| 2026Q1 | $0.17 | $0.03 | -$0.13 | -$0.13 |
| 2025Q4 | $0.28 | -$0.21 | -$0.05 | -$0.05 |
| 2025Q3 | $0.27 | -$0.25 | -$0.09 | -$0.09 |
| 2025Q2 | $0.34 | -$0.25 | -$0.22 | -$0.22 |
TLSI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.11 |
| 2026Q1 | 0% | 33.33 |
| 2025Q4 | 0% | -8.31 |
| 2025Q3 | 0% | -1.21 |
| 2025Q2 | 0% | -5.05 |
TLSI
Price: $5.24
52 week price:
Earnings Per Share: -1.32 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 351.6 million